|
HHS Viral Hepatitis Interagency Working Group
|
Other
|
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, SAMHSA
|
NIDDK, CC, NCCAM, NCI, NHLBI, NIAAA, NIAID, NICHD, NIDA, NIMHD, OD/DPCPSI/OAR
|
The HHS Viral Hepatitis Interagency Working Group was created by the Office of the Assistant Secretary for Health to address a recent report sponsored by the Institute of Medicine entitled Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. The group meets to discuss collaborations and activities directed at achieving the goals for viral hepatitis research and control highlighted in the IOM report.
|
|
HHS Working Group on Tobacco Control in Behavioral Health
|
Other
|
CDC, FDA, HRSA, OS, SAMHSA
|
NIDA, NCI, NIMH
|
The working group is a subcommittee of the HHS Tobacco Control Steering Committee. It is co-chaired by NIDA and SAMHSA, and was formed to initiate and coordinate cross-agency activities to promote, in behavioral health settings, the implementation of tobacco free policies and the integration of tobacco cessation.
|
|
HHS-Trauma, Emergency Care and Emergency Medical Services working group
|
Other
|
OS
|
NICHD
|
This workgroup documents HHS wide emergency related activities (including research) for the Assistant Secretary''s informational purposes
|
|
HHS/BARDA Radiological/Nuclear Working Group on Blood and Tissue Products
|
Meeting/ Workshop
|
CDC, FDA, OS
|
NIAID
|
This working group coordinates requirements, needs, and research and development directions for blood and tissue products for mass casualty treatment after a radiation emergency.
|
|
HIV Prevention Trials Network feasibility study (HPTN 065)
|
Research Initiative
|
CDC
|
NIAID, NIDA, NIMH
|
HPTN 065 is a feasibility study of an enhanced testing, linkage to care, and treatment approach to HIV prevention in the US, an intervention approach known as TLC-Plus. The study will involve evaluation of the feasibility of some components and the effectiveness of others.
TLC-Plus uses innovative approaches, including 1) a community focus, 2) multi-component strategies that include behavioral and biomedical interventions, 3) the use of routinely reported HIV surveillance data to determine key outcomes, and 4) a partnership with local Departments of Health and the Centers for Disease Control and Prevention.
This study will serve as a proof-of-concept formative study. It will provide key information that could guide the design and anticipate the costs of a future, large, randomized, community-level clinical trial of full implementation of a test-and-treat strategy in the U.S. Findings from this study could also inform test-and-treat efforts in other developed countries with epidemics similar to that in the U.S.
|
|
HIV/AIDS Cancer Match Study
|
Research Initiative
|
CDC
|
NCI
|
Investigators have used data from the NCI HIV/AIDS Cancer Match Study, in conjunction with data from the CDC surveillance program on the number of HIV-infected people in the U.S., to estimate the contribution of the HIV epidemic to the occurrence of Kaposi sarcoma, non-Hodgkin lymphoma, and cervical cancer.
|
|
HIV/AIDS Prevention Research Synthesis (PRS) Project
|
Resource Development
|
CDC, HRSA
|
NIMH, NIDA
|
The HIV/AIDS Prevention Research Synthesis (PRS) is collaboration between NIH, CDC, and HRSA involved the development of criteria for identifying evidence-based behavioral interventions for HIV medication adherence. These criteria were finalized in 2010 after a series of consultations with methodologists, HIV prevention researchers, and key federal partners. The revised criteria focus on quality of study design, quality of study implementation and analysis, and strength of evidence of efficacy.
|
|
Hospice to Palliative Care: Maximizing Patient Preferences and Cost Savings
|
Research Initiative
|
AHRQ
|
CC
|
Redesign Medicare Hospice Benefit. The goal of the study is to provide rational, patient-defined, evidence-based recommendations to inform the redesign of the Medicare hospice benefit, transitioning policy from the current hospice benefit to a more patient-centered palliative care model.
|
|
HPV Working Group for the Advisory Committee on Immunization Practices (ACIP)
|
Research Initiative
|
CDC
|
NCI
|
Advisory Committee on Immunization Practices (ACIP) Work Groups (WGs) serve in a key scientific role in support of vaccine policy development by the ACIP. ACIP WGs conduct extensive background reviews of relevant research data to develop options for recommendations for use of vaccines in the civilian population of the United States. WGs are convened solely to gather scientific information related to vaccines and the diseases they prevent, to analyze relevant issues and data, and to draft policies or options for review, deliberation and vote by the ACIP. The duties of this position include: participation in teleconferences and meetings, as well as preparation time for these meetings.
|
|
HRSA National Health Service Corps Students to Service Loan Repayment Program
|
Other
|
HRSA
|
NICHD
|
Advises HRSA on the loan repayment program
|